Gene: PIK3CA ×
Source: INFERRED ×
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs104886003
rs104886003
PIK3CA
A 0.710 GeneticVariation CLINVAR

dbSNP: rs104886003
rs104886003
PIK3CA
A 0.710 CausalMutation CLINVAR Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. 15647370

2005
dbSNP: rs104886003
rs104886003
PIK3CA
A 0.710 CausalMutation CLINVAR PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. 22271473

2012
dbSNP: rs121913279
rs121913279
PIK3CA
T 0.710 CausalMutation CLINVAR Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. 15647370

2005
dbSNP: rs121913279
rs121913279
PIK3CA
G 0.710 CausalMutation CLINVAR PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. 22271473

2012
dbSNP: rs121913279
rs121913279
PIK3CA
G 0.710 CausalMutation CLINVAR Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. 15647370

2005
dbSNP: rs121913279
rs121913279
PIK3CA
T 0.710 CausalMutation CLINVAR PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. 22271473

2012
dbSNP: rs1057519925
rs1057519925
PIK3CA
A 0.700 GeneticVariation CLINVAR

dbSNP: rs1057519941
rs1057519941
PIK3CA
G 0.700 GeneticVariation CLINVAR

dbSNP: rs1064793732
rs1064793732
PIK3CA
A 0.700 CausalMutation CLINVAR

dbSNP: rs121913272
rs121913272
PIK3CA
C 0.700 CausalMutation CLINVAR

dbSNP: rs121913272
rs121913272
PIK3CA
C 0.700 GeneticVariation CLINVAR

dbSNP: rs121913273
rs121913273
PIK3CA
A 0.700 CausalMutation CLINVAR PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. 22271473

2012
dbSNP: rs121913273
rs121913273
PIK3CA
C 0.700 CausalMutation CLINVAR

dbSNP: rs121913273
rs121913273
PIK3CA
A 0.700 CausalMutation CLINVAR Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. 15647370

2005
dbSNP: rs121913274
rs121913274
PIK3CA
C 0.700 CausalMutation CLINVAR PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. 22271473

2012
dbSNP: rs121913274
rs121913274
PIK3CA
C 0.700 CausalMutation CLINVAR Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. 15647370

2005
dbSNP: rs121913281
rs121913281
PIK3CA
T 0.700 CausalMutation CLINVAR

dbSNP: rs121913286
rs121913286
PIK3CA
A 0.700 CausalMutation CLINVAR PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. 22271473

2012
dbSNP: rs121913286
rs121913286
PIK3CA
A 0.700 CausalMutation CLINVAR Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. 15647370

2005
dbSNP: rs121913287
rs121913287
PIK3CA
A 0.700 GeneticVariation CLINVAR

dbSNP: rs397517201
rs397517201
PIK3CA
G 0.700 CausalMutation CLINVAR PIK3CA mutation associates with improved outcome in breast cancer. 19671852

2009
dbSNP: rs397517201
rs397517201
PIK3CA
G 0.700 CausalMutation CLINVAR PIK3CA-activating mutations and chemotherapy sensitivity in stage II-III breast cancer. 18371219

2008
dbSNP: rs397517201
rs397517201
PIK3CA
G 0.700 GeneticVariation CLINVAR

dbSNP: rs397517201
rs397517201
PIK3CA
G 0.700 CausalMutation CLINVAR Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer. 20177704

2010